Cytology of nonneoplastic occupational and environmental diseases of the lung and pleura

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 11, 2007, Pages 1700-1708

  Laucirica, Rodolfo ^a,b   Ostrowski, Mary L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS BODY; ASBESTOSIS; CELL HYPERPLASIA; CELL PROLIFERATION; CHARCOT LEYDEN CRYSTAL; CLINICAL FEATURE; CONTROLLED STUDY; CREOLA BODY FORMATION; CRYSTALLIZATION; CURSCHMANN SPIRAL FORMATION; CYTODIAGNOSIS; DIAGNOSTIC VALUE; ENVIRONMENTAL DISEASE; GOBLET CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; MESOTHELIUM CELL; METAPLASIA; OCCUPATIONAL LUNG DISEASE; PLEURA DISEASE; PROTEINOSIS; RESERVE CELL HYPERPLASIA; RESPIRATORY TRACT EXAMINATION; REVIEW; SILICOPROTEINOSIS;

CELL PROLIFERATION; ENVIRONMENTAL EXPOSURE; HUMANS; INCLUSION BODIES; LUNG DISEASES; METAPLASIA; OCCUPATIONAL DISEASES; PLEURAL DISEASES;

EID: 35948973481     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. International Labour Office. Guidelines for the Use of ILO International Classification of Radiographs for Pneumoconiosis. Revised Edition 2000. Geneva, Switzerland: International Labour Office; 2002:1-43. Occupational Safely and Health Series, No. 22.
2. Churg A, Green FH. Pathology of Occupational Lung Disease. 2nd ed. Baltimore: Williams & Wilkins; 1998.
3. Kayacan O, Beder S, Karnak D. Cellular profile of bronchoalveolar lavage fluid in Turkish miners. Postgrad Med J. 2003;79:527-530.
4. Costabel U, Donner CF, Halsam PL, et al. Occupational lung diseases due to inhalation of inorganic dust. In: Klech H, Hutter C, eds. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J. 1990;3:946-949.
5. Begin R, Bisson G, Boileau R, Masse S. Assessment of disease activity by gallium-67 scan and lung lavage in the pneumoconiosis. Semin Respir Med. 1986;7:271-280.
6. Ferrer J, Garcia-Valero J, Montes JF. Pleural reaction to mineral dust. In: Light RW, Lee YCG, eds. Textbook of Pleural Diseases. London, England: Arnold; 2003:109-119.
7. Sporn TA, Butnor KJ, Roggli VL. Cytopathology of asbestos-associated diseases. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, NY: Springer; 2004:231-255.
8. Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Muller NL, King TE. Occupational lung diseases and pneumoconioses. In: Nonneoplastic Disorders of the Lower Respiratory Tract. Washington DC: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002:793-857.
9. Musk AW, De Klerk NH. Benign asbestos pleural diseases. In: Light RW, Yee YCG, eds. Textbook of Pleurat Diseases. London, England: Arnold; 2003:428-434.
10. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982;247:617-622.
11. Naylor B. The shedding of the mucosa of the bronchial tree in asthma. Thorax. 1962;17:69-72.
12. Naylor B, Railey C. A pitfall in the cytodiagnosis of sputum of asthmatics. J Clin Pathol. 1964;17:84-89.
13. Lam S, LeRiche J, Phillips D, Chan-Yeung. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. Am Rev Respir Dis. 1987;80:44-50.
14. Agust C, Xaubet A, Arriols R, et al. Multinuclear giant cells in bronchoalveolar lavage in interstitial lung diseases. Respiration. 1987;51:307-311.
15. Kern I, Kecelj P, Kosnik M, Mermolja M. Multinucleated giant cells in bronchoalveolar lavage. Acta Cytol. 2003;47:426-430.
16. Kinoshita M, Sueyasu Y, Watanabe H, et al. Giant cell interstitial pneumonia in two hard metal workers: the role of bronchoalveolar lavage in diagnosis. Respirology. 1999;4:263-266.
17. Davison AG, Haslam PI, Corrin B, et al. Interstitial lung disease and asthma in hard metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax. 1983;38:119-128.
18. Fraig M, Shreesha U, Savici D, Katzenstein A-LA. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26:647-653.
19. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979;97:149-206.
20. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis. 1990;142:642-647.
21. Travis WD, Colby TV, Koss MN. Rosado-de-Christenson ML, Muller NL, King TE. Hypersensitivity pneumonitis. In: Nonneoplastic Disorders of the Lower Respiratory Tract. Washington DC: American Registry of Pathology and the Armed Forces Institute of Pathology; 2002:115-123.
22. Embil j, Warren P, Yakrus M, et al. Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tube water: hypersensitivity pneumonitis or infection? Chest. 1997;111:813-816.
23. Satake N, Nagai S, Kawatani A, et al. Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonitis, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia. Eur Respir J. 1993;6:477-482.
24. Rossi GA, Sacco O, Cosulich E, et al. Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity. Thorax. 1984;39:143-149.
25. Reynolds SP, Jones KP, Edwards JH, Davies BH. Inhalation challenge in pigeon breeder's disease: BAL fluid changes after 6 hours. Eur Respir J. 1993;6:467-476.
26. King TE Jr. Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis). Available at: www.patients.uptodate.com. Accessed August 2007.
27. Newman LS, Kreiss K, King TE, Seay S, Campbell PA. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis. 1989;139:1479-1486.
28. Sawyer RT, Day BJ, Fadok VA, et al. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004;31:470-477.
29. Curschmann H. Einege bermerkungen uber die im bronchial secret vorkommenden spiralen. Deutsches Arch J Klin Med. 1885;36:578-585.
30. Antonakopoulos GN, Lambrinaki E, Kyrkou KA. Curschmann's spirals in sputum: histochemical evidence of bronchial gland duct origin. Diagn Cytopathol. 1987;3:291-294.
31. Naylor B, Novak PM. Charcot-Leyden crystals in pleural fluids. Acta Cytol. 1985;29:781-784.
32. Dumortier P, Broucke I, De Vuyst P. Pseudoasbestos bodies and fibers in bronchoalveolar lavage of refractory ceramic fibers. Am J Respir Crit Care Med. 2001;164:499-503.
33. Dodson RF, Greenberg SD, Williams MG, Corn CJ, O'Sullivan MF, Hurst GA. Asbestos content in lungs of occupationally and nonoccupationally exposed individuals. JAMA. 1984;252:68-71.
34. Dodson RF, Williams MG, Huang J, Bruce JR. Tissue burden of asbestos in nonoccupationally exposed individuals from East Texas. Am J Ind Med. 1999;35:281-286.
35. Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med. 1986;43:18-28.
36. De Vuyst P, Dumortier P, Moulin E, et al. Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir J. 1988;1:362-367.
37. Sebastien P, Armstrong B, Munchaux G, Bignon J. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis. 1988;137:75-78.
38. Roggli VL, Piantadosi CA, Beell DY. Asbestos bodies in bronchoalveolar lavage fluid. A study of 20 asbestos-exposed individuals and comparison to patients with other chronic interstitial lung diseases. Acta Cytol. 1986;30:470-476.
39. Roggli VL, Coin PG, MacIntyre NK, Bell DY. Asbestos content of bronchoalveolar lavage fluid: a comparison of light and scanning electron microscopic analysis. Acta Cytol. 1994;38:502-510.
40. Vathesatogkitt P, Harkin TJ, Addrizzo-Harris DJ, Bodkin M, Crane M, Rom WN. Clinical correlation of asbestos bodies in BAL fluid. Chest. 2004;126:966-971.
41. Nugent KM, Pesanti EL. Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis. 1983;328:406-410.
42. Burkhalter A, Silverman JF, Hopkins MB, Geisinger KR. Bronchoalveolar lavage cytology in pulmonary alveolar proteinosis. Am J Clin Pathol. 1996;106:504-510.
43. Mikami T, Yamamoto Y, Yokoyamn M, Okayasu I. Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid. J Clin Pathol. 1997;50:981-984.
44. Chou C-W, Lin F-C, Tung S-M, Liou R-D, Chang S-C. Diagnosis of pulmonary alveolar proteinosis: usefulness of Papanicolaou-stained smears of bronchoalveolar lavage fluid. Arch Intern Med. 2001;161:562-566.
45. Keller CA, Frost A, Cagle PT, Abraham JL. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest. 1995;108:277-280.
46. 4b. Buechner HA, Anasari A. Acute silico-proteinosis: a new pathologic variant of acute silicoproteinosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest. 1969;55:274-278.
47. Xipell JM, Ham KN, Price CG, Thomas DP. Acute silicoproteinosis. Thorax 1977;32:104-111.
48. Laga AC, Allen T, Ostrowski M, Cagle PT. Reactive changes, nonspecific findings, and age-related changes. In: Cagle PT, ed-in-chief. Color Atlas and Text of Pulmonary Pathology. Baltimore, Md: Lippincott, Williams & Wilkins; 2005:27.